Life Insurance With Hepatitis B and C: How to Get Covered

Most people with hepatitis can qualify for life insurance, but eligibility and rates depend on the type (B or C), disease status, and liver health. Insurers assess viral load, liver function and treatment compliance to determine pricing.

Hepatitis affects underwriting because it increases the risk of liver disease progression, cirrhosis and hepatocellular carcinoma. Underwriters assess mortality risk through viral load and liver enzyme panels. Omitting your hepatitis diagnosis on an application is material misrepresentation. If found during underwriting or within the contestability period after a claim, the insurer can rescind the policy or deny the death benefit.

Insurers treat hepatitis B and hepatitis C differently based on infection activity, viral load and liver damage. Chronic hepatitis B carriers with undetectable viral loads and normal liver enzymes often qualify for standard or substandard ratings. Active hepatitis B with elevated ALT/AST levels results in table ratings or postponement until the infection is controlled:

Life insurance underwriters request liver biopsy results, viral load test results, ALT and AST enzyme levels, treatment history and confirmation of no cirrhosis or hepatocellular carcinoma. These data points establish the severity of liver damage and the likelihood of disease progression. Missing documentation or gaps in your treatment timeline can trigger higher rating classes or postponement.

Your final rating class depends on your age, liver health, treatment compliance and, for hepatitis C, time since achieving SVR. A 35-year-old with managed hepatitis B, normal liver function and no other health conditions will pay substandard or table-rated premiums. A 50-year-old with active hepatitis C and elevated liver enzymes will pay substandard or table-rated premiums, if approved.

Health ratings directly affect life insurance premiums. Lower ratings mean higher costs. Hepatitis applicants are usually rated at Average or Fair, with Fair being the most common for well-managed cases without other major conditions. Active infection or documented liver damage results in higher table ratings or denial.

A 40-year-old male with hepatitis can expect to pay an average of $66 per month for a 20-year term, $500,000 policy, while a female of the same age pays an average of $52. The rates below reflect a Fair health rating for a nonsmoker purchasing a 20-year term policy with $500,000 in coverage:

• Term life insurance. Most applicants with managed hepatitis B or treated hepatitis C qualify for term life insurance, though at substandard rates.
• Permanent life insurance. Universal and whole life insurance are possible, depending on your liver health. People with no cirrhosis and normal liver function have the best odds of qualifying for permanent coverage.
• Guaranteed issue whole life. Applicants declined for standard coverage can get guaranteed issue whole life. These policies don't require medical questions and can't be denied based on your health status, but coverage is capped at $30,000 and premiums are higher per dollar of coverage. If you need immediate coverage or have been declined elsewhere, no-exam life insurance is an accessible alternative.

A denial from one insurer doesn't mean you can't get coverage. Underwriting standards vary, and a specialist broker can help find insurers with more flexible guidelines for hepatitis. Some companies may decline applicants that others approve at standard or substandard rates.

Request the reason for denial in writing. Correct any medical record errors, make sure all treatment documentation is complete and wait the required period after treatment before reapplying. Many applicants who are initially declined can qualify after demonstrating sustained improvement in liver function or achieving SVR.